Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence-Reference-Cited by-同舟云学术

Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence

Published:2013-10 Issue:2 Volume:95 Page:151-155
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Conesa-Zamora Pablo,Torres-Moreno Daniel,Isaac María A,Pérez-Guillermo Miguel

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference29 articles.

1. Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors;Argyriou;Molecular Medicine,2009

2. Absence of epidermal growth factor receptor mutations in cervical cancer;Arias-Pulido;International Journal of Gynecological Cancer,2008

3. Epidermal growth factor receptor expression and the presence of human papillomavirus in cervical squamous intraepithelial lesions;Chapman;International Journal of Gynecological Pathology,1992

4. HER2 expression in cervical cancer as a potential therapeutic target;Chavez-Blanco;BMC Cancer,2004

5. Effect of human papillomavirus on cell cycle related proteins p16, Ki67, cyclin D1, p53 and ProEx C in precursor lesions of cervical carcinoma. A tissue microarray study;Conesa-Zamora;American Journal of Clinical Pathology,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of the Mechanisms by Which Quercetin Enhances Cisplatin Action in Cervical Cancer: A Network Pharmacology Study and Experimental Validation;Frontiers in Oncology;2022-01-06

2. Mutations in the helix αC of the catalytic domain from the EGFR affect its activity in cervical cancer cell lines;Oncology Letters;2022-01-05

3. Distinguishing features of a novel humanized anti-EGFR monoclonal antibody based on cetuximab with superior antitumor efficacy;Expert Opinion on Biological Therapy;2021-11-02

4. Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis;PLOS ONE;2021-09-30

5. Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpoints;Archives of Gynecology and Obstetrics;2021-08-15